Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17891917 | 0.98 | ANPEP (0.33) | ANPEP | |
| SCHEMBL5953079 | 0.94 | ANPEP (0.41) | ANPEP | |
| SCHEMBL9903702 | 0.80 | — | — | |
| SCHEMBL1300947 | 0.80 | — | — | |
| SCHEMBL290668 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL17652427 | 0.74 | FAAH (0.38) | — | |
| SCHEMBL3709629 | 0.73 | — | — | |
| SCHEMBL1726025 | 0.71 | ANPEP (0.46) | ANPEP | |
| SCHEMBL10624549 | 0.70 | — | — | |
| SCHEMBL18074209 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115490715-A | Method for preparing aryl boronic acid pinacol ester compound by taking phenol as raw material | 遵义医科大学 | 2022-12-20 | — | — | CN | claimed |
| CN-115286553-A | Preparation method of indole compound | 浙江理工大学 | 2022-11-04 | — | — | CN | claimed |
| CN-113956185-A | Method for efficiently preparing aromatic urea compound | 常州大学 | 2022-01-21 | — | — | CN | claimed |
| CN-109896977-B | Synthetic method of biaryl phenol ester | 吉林大学 | 2021-09-28 | — | — | CN | claimed |
| US-20240217972-A1 | GLUTARIMIDE-CONTAINING PAN-KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | TIGER BIOTHERAPEUTICS INC. | 2024-07-04 | — | — | US | disclosed |
| US-20240216516-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | TIGER BIOTHERAPEUTICS INC. | 2024-07-04 | — | — | US | disclosed |
| WO-2024145273-A2 | N-MYRISTOYLTRANSFERASE INHIBITORS AND METHODS OF USE | SEATTLE CHILDREN'S HOSPITAL (D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE) (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024118960-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | TIGER BIOTHERAPEUTICS INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024118966-A1 | GLUTARIMIDE-CONTAINING PAN-KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | TIGER BIOTHERAPEUTICS INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| EP-4359395-A1 | HERBICIDAL ARYLCYCLOPENTENE CARBOXAMIDES | BASF SE (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4359396-A1 | HERBICIDAL ARYLDIHYDROFURANE CARBOXYLATES | BASF SE (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-11945830-B2 | Antiviral heterocyclic compounds | ENANTA PHARMACEUTICALS, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| EP-2592154-A1 | Immobilization products and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins | CELLZOME AG (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-8288604-B2 | Method of rapid methylation, kit for preparing PET tracer and method of producing PET tracer | GIFU UNIVERSITY (JP) | 2012-10-16 | — | — | US | disclosed |
| WO-2012052390-A1 | N-2-(2-PYRIDINYL)-4-PYRIMIDINYL-BETA-ALANINE DERIVATIVES AS INHIBITORS OF HISTONE DEMETHYLASE JMJD3 | GLAXO GROUP LIMITED (GB) | 2012-04-26 | — | — | WO | disclosed |
| US-20120046278-A1 | THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2012-02-23 | — | — | US | disclosed |
| EP-2405973-A2 | THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS | Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) | 2012-01-18 | — | — | EP | disclosed |
| US-20100249477-A1 | Method of Rapid Methylation, Kit for Preparing PET Tracer and Method of Producing PET Tracer | GIFU UNIVERSITY (JP) | 2010-09-30 | — | — | US | disclosed |
| WO-2010103130-A2 | NOVEL BICYCLIC HETEROCYCLES | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2010-09-16 | — | — | WO | disclosed |
| EP-2070897-A1 | METHOD OF RAPID METHYLATION, KIT FOR PREPARING PET TRACER AND METHOD OF PRODUCING PET TRACER | Gifu University (JP) | 2009-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216516-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | KRAS, VHL, HRAS | ANPEP 3073/4885 |
| US-20100249477-A1 | Method of Rapid Methylation, Kit for Preparing PET Tracer and Method of Producing PET Tracer | DNMT1, MAP2K1, DOT1L | ANPEP 1376/4885 |
| US-20120046278-A1 | THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS | TPMT, STAT6, IL4 | ANPEP 4420/4885 |
| US-20240217972-A1 | GLUTARIMIDE-CONTAINING PAN-KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | KRAS, VHL, HRAS | ANPEP 2863/4885 |
| US-11945830-B2 | Antiviral heterocyclic compounds | ACE, HPRT1, ACE2 | ANPEP 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.